This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2020
Title: **Andrei Igorevich Voznesensky: Innovator in Monoclonal Antibodies**
Introduction
Andrei Igorevich Voznesensky, situated in Arlington, MA, is a prominent inventor with a keen focus on biopharmaceutical innovations. With a total of three patents, he is making significant contributions to the field of medicine, particularly through his work on monoclonal antibodies.
Latest Patents
Voznesensky's latest patents include groundbreaking research on Angiopoietin-like 4 antibodies. The first patent titled "Angiopoietin-like 4 antibodies and methods of use" relates specifically to monoclonal antibodies that bind to the human angiopoietin-like 4 protein (often abbreviated as ANGPTL4). This invention encompasses pharmaceutical compositions and methods of treatment utilizing these antibodies. The second patent, "Angiopoietin-like 4 (ANGPTL4) antibodies and methods of use," echoes this advancement, further exploring the therapeutic applications of ANGPTL4 antibodies.
Career Highlights
Currently, Voznesensky is affiliated with Novartis AG, where he continues to push the boundaries of medical science through his innovative work. His expertise in the field has positioned him as a valuable asset within the organization, driving forward-looking solutions that address critical health challenges.
Collaborations
Throughout his career, Voznesensky has collaborated with notable colleagues such as John Trauger and Julia Neugebauer. These partnerships have fostered an environment of creativity and innovation, allowing for the exchange of ideas and the pursuit of shared goals in biotechnology.
Conclusion
Andrei Igorevich Voznesensky's contributions to the field of monoclonal antibodies reflect a commitment to advancing medical science. With his innovative patents and collaborative spirit, he is undoubtedly a key figure in the ongoing pursuit of effective therapeutic solutions. His work not only enhances our understanding of biological mechanisms but also paves the way for future breakthroughs in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile